We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BYLOT:ATHEXBallys Intralot S.A. Analysis

Data as of 2026-05-31 - not real-time

€1.19

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical momentum remains strong with the price trading above its short‑term averages and the relative strength index perched in the upper range, suggesting continued buying pressure. However, the moving‑average convergence divergence has just turned bearish, and the price is flirting with a key resistance level, indicating a potential short‑term pullback.
Fundamentally, the company appears deeply discounted relative to its discounted cash‑flow estimate, implying a sizable upside, but this is tempered by negative earnings, a thin profit margin, and an exceptionally high leverage ratio that raises concerns about financial stability. The sector’s cyclical nature and the regulatory environment for gambling add further layers of uncertainty, while the stock’s volatility is elevated and the beta remains modest, reflecting a mix of market sensitivity and defensive characteristics.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Momentum indicators remain bullish but MACD signals a near‑term reversal
  • Price is approaching a prominent resistance level
  • Elevated short‑term volatility could trigger price swings

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • DCF model suggests material upside potential
  • Current earnings are negative and leverage is extremely high
  • Sector cyclicality may moderate performance over the next several quarters

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap provides room for appreciation if profitability improves
  • Rebranding and strategic focus on digital gaming could drive future growth
  • Long‑term industry trends favor expansion of online gambling platforms

Key Metrics & Analysis

Financial Health

Revenue Growth104.80%
Profit Margin-12.59%
P/E Ratio13.2
ROE-8.41%
ROA2.43%
Debt/Equity124.67
P/B Ratio1.6
Op. Cash Flow€158.5M
Free Cash Flow€227.0M

Technical Analysis

TrendBullish
RSI69.1
Support€1.09
Resistance€1.19
MA 20€1.14
MA 50€1.04
MA 200€1.02
MACDBearish
VolumeIncreasing
Fear & Greed Index94.07

Valuation

Fair Value€3.64
Target Price€1.35
Upside/Downside13.92%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.41
Volatility25.77%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.